AEterna Zentaris Inc. (AEZS)

[MinnieM]

Whoever had the website updated appears to be concerned about sick patients, not investors. And, someone at the institution has obviously seen some positive results or they wouldn't be expecting an FDA approval as likely. I highly doubt anyone from the hospital is going to say it's an encouragement for investors to buy. The page in question clearly wasn't designed for investors. And, the middle paragraph that has been quoted extensively was removed today. Due to your inquiry I'm guessing. I wish I'd taken a screen shot last night.

Page in question for those that haven't followed conversation:

"Recently, UT Southwestern participated in a study of a drug called zoptarelin doxorubicin that is expected to be the first FDA-approved drug for endometrial cancer"

Under
Access to the Latest Treatment, middle paragraph, last sentence not removed.

http://www.utswmedicine.org/cancer/programs/gynecologic/

In Reply to 'chmcnfunds'
Yes, I noted to him that privileged information regarding AEZS has SEC and other consequences and asked that he clarify whether the information was a leak and could it be an encouragement for investors to buy.

Hopefully, he will clarify.

AEEZS